CDS Final Guidance Infringes On Free Speech, Professor Says
Executive Summary
A citizen petition filed by a University of Florida Law Professor posits that the FDA’s CDS Guidance violates the first amendment.
You may also be interested in...
Digital Health Roundup: What’s Hot On Investment; Diabetes; AI
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb looks back at ADA 2023 highlights and her interviews with diabetes company execs. Reed Miller discusses his Cardio Conversation with Volta Medical and Hannah Daniel discusses the FDA’s Clinical Decision Support Software final guidance.
Petition Argues FDA’s CDS Software Guidance Violates The Law
CDS Coalition legal counsel Bradley Thompson broke down the citizen petition calling for the US FDA to rescind the Clinical Decision Software guidance based on legal and procedural violations.
Expert: New Guidance May Demand Clinical Decision Support Software Re-Evaluation
Businesses should reevaluate the classification of their clinical decision software based on a new FDA guidance, Kyle Faget of Foley & Lardner LLP tells Medtech Insight.